Summary The prognostic weight of histological and biological factors was compared with that of known clinical prognostic factors in a population of 108 consecutive previously untreated patients with head and neck squamous cell carcinoma. Parameters studied were: tumour vascularisation, mitotic index, histological differentiation, nuclear grade, keratinisation, desmoplasia, growth pattern, inflammation, tumour emboli in peripheral vessels, keratins 6, 13, 19 immunohistochemical expression, cytofluorometric ploidy and S-phase. In multivariate analysis (Cox), only age and nodal status had a significant impact on overall survival, whereas T stage was the only significant factor associated with locoregional failure. The cumulative incidence of metastases was correlated not only with age, T and N stage, but also with histological differentiation. All the other histological and biological factors studied failed to provide further prognostic information. These findings may help to select patients with high metastatic risk.
Numerous factors have been evaluated for their potential prognostic influence in patients with newly diagnosed head and neck squamous cell carcinoma (HNSCC). These can be divided into patient-related, tumour-related and/or treatmentrelated parameters. Traditional tumour-related factors currently used in the therapeutic decision are primary tumour location and extension, nodal involvement and distant metastatic spread. Patient-related factors such as age, co-morbidity (cirrhosis, emphysema etc.) or patients' performance status are also important for the decision regarding the specific choice of the therapeutic modalities to be recommended.
Histological grading based on Broders' initial classification (Broders, 1920 ) is a standard pathological diagnostic parameter, with recognised value in different oncological entities. This, however, has not been consistently substantiated in HNSCC owing to the inherent subjectivity in the grading systems (Ensley et al., 1986; Roland et al., 1992) . Extensive scoring methods have been introduced to histological grading to minimise subjectivity and to improve the prognostic accuracy (Jacobsson et al., 1973; Crissman et al., 1984; Anneroth et al., 1986; Zatterstrom et al., 1991; Barona de Guzman et al., 1993) .
Recently, specific factors such as qualitative and quantitative cytokeratin expression (Van der Velden et al., 1993 , Klijanienko et al., 1993 tumour vascularisation (tumour invasion of vessels and angiogenesis) (Weidner et al., 1991) and tumour DNA content have been evaluated. The value of ploidy as an independent prognostic parameter in heterogeneous solid tumours remains moot and controversial (Merkel and McGuire, 1990 ) and seems to be linked to treatment modalities (Ensley and Maciorowski, 1994) . It has been reported that aneuploid tumours are more chemosensitive (Gregg, 1993) but the correlation with response to radiotherapy is not clear (Walter et al., 1991; Ensley and Maciorowski, 1994) .
Determining tumoral proliferative activity has been a subject of interest for many decades (Tubiana, 1993 ) and a number of semiroutine immunohistochemical techniques has recently become available for its determination  proliferating cell nuclear antigen (PCNA), bromodeoxyuridine (BUDR)]. Highly proliferative tumours can benefit from particular radiotherapeutic modalities (Begg et al., 1990) . However, none of these histobiological factors has been confirmed to have a better prognostic value than clinical staging by the TNM classification.
The present prospective study was designed (1) to address the relationship between clinical, histological and/or biological factors in HNSCC, (2) to compare the prognostic weight of histological and biological factors to that of known clinical prognostic factors.
To this effect, all previously untreated and newly diagnosed patients with a single primary HNSCC tumour, treated over 1 year in our institution, were prospectively biopsied for diagnosis. A simplified version of Crissman and Jacobsson criteria of histological grading and differentiation as complemented with histological and immunohistochemical determination of keratins, mitotic index and vascular count. Their quantification was subjected to inter-and intraobserver validation assessment.
Tumoral ploidy (DNA index and S-phase percentage) was also determined on fresh tissue samples. All these parameters were validated for feasibility and variance through semiquantitative and qualitative scales. The interrelationship of these factors has been reported elsewhere (De Braud et al., 1991) and will not be detailed here. Their eventual prognostic weight was statistically analysed and correlated with clinically relevant end points of treatment outcome, clinical progression pattern and overall survival.
In the present paper we report the prognostic impact of parameters studied on the overall survival and cumulative incidence of locoregional failures and metastases with a minimum follow-up of 2 years.
Materials and methods Patients
The initial materials for this study consisted of 148 consecutive specimens from newly diagnosed and untreated patients with HNSCC biopsied for diagnosis and the present study in our institution between August 1989 and September 1990. Of these, 11 biopsies were not suitable for analysis (small samples, technical problems, negative biopsies) and 15 patients had multiple primary tumours diagnosed simultaneously in head and neck sites. Histological examination Fresh biopsies were fixed in formalin and embedded in paraffin. The quality of material was checked by frozen sections. Sections (4 yim) were stained with haematoxylin and eosin for histological evaluation, vascular count (TV) and mitotic index (MI).
Different histological parameters were evaluated and tumours were graded as follows: well-(WD), moderately (MD) and poorly differentiated (PD) depending on the degree of keratin pearl formation, keratinisation and overall resemblance of carcinoma to normal squamous epithelium according to World Health Organization criteria (World Health Organization, 1978) . Other parameters were assessed according to a modification of grading system (Crissman et al., 1984) : degree of keratinisation (1, strongly keratinised; 2, keratinised; 3, slightly keratinised; 4, unkeratinised); nuclear grade (1, regular nuclei; 2, slight atypia; 3, strong; 4, severe); growth pattern (1, pushing borders; 2, large sheets; 3, fine sheets; 4, isolated cells); desmoplasia (1, hyalinised; 2, fibrous; 3, partially fibrous; 4, oedema); inflammatory infiltrates (1, acute; 2, subacute; 3, chronic or small infiltrates; 4, not inflammatory).
TV and MI were counted at x 400 (31 x 31 Mm) in ten consecutive randomly chosen fields in the area of high capillary density (angiogenesis). Fields presenting less than 50% of tumour tissue were eliminated. Vascular dilated areas, haemorrhagic and necrotic or fibrotic areas were omitted. TV was evaluated as a numeric score of all sections of all anatomical types of vessels (with or without erythrocytes). MI was counted in the same fields analysed for vascularisation. For MI the cut-off point was 25 mitosis per ten high-power fields (HPFs). For TV, we tested three different cut-off points: 20, 30, 40 vessels x ten HPFs. Vascular invasion by tumour cells were also determined for each biopsy in the peripheral microvessels. Tumour emboli in the vascular micronetwork was defined as absent or present.
The quantitative score regarding tumour vascularisation and mitotic index was established through two separate evaluations by the same pathologist (JK, intraobserver variance) as well as readings by three other pathologists (intraobserver variance). The second reading by the original pathologist (JK) was chosen as the set of data to be analysed, having the smallest variance. Results with variance analysis of intra-and inter-observer variations has already been reported (Klijanienko et al., 1995) . The distribution of patients according to first treatment and histological parameters is presented in Table III) .
Immunohistochemical keratin staining was carried out on unstained paraffin-embedded sections, with the use of the peroxidase -antiperoxidase method as described previously (Klijanienko et al., 1989 Table IV .
All histopathological assessments, ploidy and S-phase determinations were performed blind to the patients characteristics, treatment and outcome.
Follow-up
Patients were followed up quarterly with clinical examination of the head and neck and routine chest radiograph. A liver ultrasound and a bone scan were included if there was clinical or biological suspicion of metastasis. Patients' clinical status was reviewed in January 1993, that is 26 months after the last patient was included in the study. There were no follow-up losses. The median follow-up is 32 months (range 26-38). The cut-off date for analysis was 1 January 1993.
Statistical analysis
The semiquantitative variables were analysed in two groups (I + II vs III + IV) and qualitative and semiquantitative variables were displayed in contingency tables and analysed by the chi-square test (with Yates' correction when appropriate).
The prognostic value of all mentioned parameters was studied in univariate analysis for three end-points: overall (Mantel, 1966) . All reported P-values are two-sided. The event rates are given with their standard deviation (s.d.) . Multivariate analysis was used to determine the independent prognostic value of the selected variables, using Cox's proportional hazards regression model with a forward stepwise regression (Cox, 1972) . It was performed for each end point, taking into the model all the variables with a Pvalue <0.02 in the univariate analysis. These analyses were stratified on tumour site because the evaluation of the prognostic value of tumour site was not the main aim of this study. Tables III and IV The correlation between histopathological and biological parameters is being reported in detail elsewhere (Klijanienko et al., 1995 The histopathological assessment of surgical specimens in our study revealed 12 cases in which margins were positive for tumour or too close for comfort (doubtful) among 61 cases submitted to surgery. Eleven of those cases were among the 48 patients having surgery as the initial therapeutic procedure, whereas one case was among the 29 patients having neoadjuvant chemotherapy.
Results

Histobiological studies
Two patients of the 11 with positive margins in the initial surgery group had local recurrence (on primary tumour site), whereas three had a neck recurrence. In the 37 patients of the surgery first group in which margins were considered adequate, there were eight local recurrences and three nek recurrences (two of them both neck and primary). In the 11 patients with neoadjuvant chemotherapy in which surgical margins were negative and adequate, there was a single local recurrence. The differences are not statistically significant.
Univariate analysis (Table VI) Overall survival The overall 2 year survival was 65.5% (+ 0.05), whereas the disease-free survival at 2 years was 50%. The (7) 66 (5) 64 (13) 67 (6) 55 (9) 90 (9) 75 (7) 61 (6) 76 (6) 57 (6) 66 (9) 65 (5) 59 (7) 71 (6) 64 (6) 68 (7) 68 (8) 65 (6) 70 (7) 62 (6) 67 (6) 63 (7) 66 (6) 65 (8) 65 (12) 64 (8) 65 (8) 62 (7) 59 (7) 76 (6) 64 (7) 71 (6) 66 (6) 65 (7) 64 (6) 68 (8) 66 (7) 67 (7) 0.02
326 (76) 0.32
30 (5) 14 (9) 30 (6) 0.04 29 (8) 20 (13) 0.21 21 (7) 36 (6) 30 (11) 36 (9) 0.74 34 (8) 27 (7) 0.38 30 (7) 23 (6) 0.71
239 (6) 0.85 29 (6) 26 (7) 0.72 32 (6) 23 (7) 0.98
27 (6) 27 ( (7) 22 (4) 30 (13) 20 (5) 32 (9) 18 (12) 9 (5) 30 (6) 6 (4) 36 (6) 42 (9) 15 (4) 20 (6) 25 (6) 14 (4) 35 (7) 22 (8) 23 (5) 15 (5) 29 (6) 18 (5) 30 (7) 17 (4) 36 (9) 24 (10) 26 (8) 25 (8) 25 (7) 30 (7) 15 (5) 22 (6) 23 (6) 25 (6) 19 (6) 20 (5) 29 (8) 28 (7) (hypopharynx + epilarynx vs oral cavity + oropharynx vs larynx; P=0.04) and N stage (NO vs NI-2-3, P=0.Ol) (Figure 1) , were the only significant factors for overall survival. Histological parameters, as well as ploidy or 5-phase, did not reveal any statistically significant effect on survival.
Cumulative incidence of locoregional failures The cumulative incidence of locoregional failures with or without metastases at 2 years is 31% (± 0.04). The only factor with borderline significance in univariate analysis was T stage (Ti +T2 vs T3 +T4, P=0.06).
Cumulative incidence of metastases The cumulative incidence of metastases with or without locoregional failures at 2 years is 24% (± 0.04). Significant clinical factors were nodal status (NO vs NI-2 -3) (Figure 2) Our study had two aims within its prospective methodology: the first was the assessment of the reliability and feasibility of different techniques in a routine clinical setting. The second was the determination of their prognostic weight against three different clinically relevant end points (overall survival, cumulative incidence of locoregional recurrences and cumulative incidence of metastases). The prognostic weight was ascertained with standard univariate and multivariate statistical methods. A systematic clinical work-up and followup routine with a minimum follow-up of 2 years and no follow-up losses in this patient population accrued in 1 year strengthens the clinical relevance of our findings.
The prognostic value of the TNM system is once again confirmed. Our study also confirms that poorly differentiated tumours generate more and larger nodal metastases, as previously described (Roland et al., 1992) . The multivariate analysis shows that, within the same T and N stage, these poorly differentiated tumours metastasise earlier and more frequently than well-or moderately differentiated ones. In this respect, the cumulative incidence of metastasis is shown to be particularly steep in its rate and as high as 50% in certain subpopulations (Figures 2-4) . Patients with poorly differentiated tumours and clinical nodal involvement are at high risk. Any therapeutic intervention aiming to eradicate or postpone the metastatic process should focus on this patient population. Our study also shows that an experienced histopathologist is still the most powerful and discriminating prognostic factor after a clinical examination and careful staging with currently available technology has been obtained. Of note is the fact that our attempt to improve the discriminative power of currently available grading systems did not succeed. The reliability of histological grading was proven by close inter-and intraobserver correlation.
Given these results, the relationship between histological differentiation and response to systemic treatment in HNSCC is of particular interest. For example, Nakashima et al. (1990) using an in vitro test of chemosensitivity have suggested that intrinsic cell chemosensitivity correlated with poor differentiation. In advanced tumours treated with combined cisplatin and radiation therapy complete response has been shown to be more frequent in the subgroup of poorly differentiated tumors (Crissman et al., 1987) . Complete response with induction chemotherapy alone correlated poorly with conventional differentiation (Ensley et al., 1987) or with other histological parameters (Ensley et al., 1988) . However, in advanced laryngeal tumours, the histological parameter 'pattern of invasion' correlated strongly with response to primary chemotherapy (Bradford et al., 1994) .
The recent association between vascular density and tumour aggressivity described initially in breast cancer has also been reported in HNSCC (Gasparini et al., 1993) . Both the present paper and Van Hoef et al. (1993) regarding breast cancer patients have failed to confirm the clinical prognostic relevance of this new parameter. In this study, cytofluorometric analysis was performed on fresh samples, as recommended by Ensley and Maciorowski (1994) We contend that the likelihood of identifying clinically valid new prognostic factors in a non-selected population of HNSCC patients is very low. The search for new tools to aid in the therapeutic decision process is likely to be more successful in specific clinical subpopulations, i.e. site-specific (larynx, nasopharynx), low nodal stage and in poorly differentiated tumours. Similarly, prospective therapeutic trials, with clinically relevant end points should be performed in specific patient populations to maximise discriminating power.
